Dyadic International (NASDAQ:DYAI) Stock Price Passes Above 50-Day Moving Average – Time to Sell?

Shares of Dyadic International, Inc. (NASDAQ:DYAI) passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.48 and traded as high as $1.93. Dyadic International shares last traded at $1.75, with a volume of 265,677 shares traded.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and set a $6.00 price target on shares of Dyadic International in a research report on Thursday, November 14th.

Dyadic International Stock Performance

The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15. The firm’s fifty day moving average price is $1.49 and its 200 day moving average price is $1.39. The firm has a market cap of $54.44 million, a P/E ratio of -8.00 and a beta of 0.89.

Dyadic International (NASDAQ:DYAI) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.06. The company had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. Sell-side analysts expect that Dyadic International, Inc. will post -0.18 EPS for the current fiscal year.

Institutional Trading of Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Chapin Davis Inc. boosted its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 868,301 shares of the biotechnology company’s stock after buying an additional 21,000 shares during the quarter. Chapin Davis Inc. owned 2.97% of Dyadic International worth $903,000 at the end of the most recent reporting period. 27.95% of the stock is owned by institutional investors.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.